Article

Analyzing Vaccine Trials in Epidemics with Mild and Asymptomatic Infection

2018-04-06

Abstract excerpt

<h4>ABSTRACT</h4> Vaccine efficacy against susceptibility to infection (VE S ), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with a high proportion of asymptomatic infection, as such infections may contribute to onward transmission and outcomes such as Congenital Zika Syndrome. However, estimating VE S is resource-intensive. We aim to identify methods to accurately estimate V...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e94fd13-ee1e-5c24-8f74-a081b7865f38
DOI: 10.1101/295337

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analyzing Vaccine Trials in Epidemics with Mild and Asymptomatic InfectionDOI 10.1101/295337Read

Leveraging pathogen sequence and contact tracing data to enhance vaccine trials in emerging epidemicsSemantic proximity Read

Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trialsSemantic proximity Read

Planning robust clinical trials for Shigella vaccines: A simulation-based evaluation of the impact of naturally-acquired immunity on vaccine performanceSemantic proximity Read

Vaccine Efficacy at a Point in TimeSemantic proximity Read

Analysis of the Potential Efficacy and Timing of COVID-19 Vaccine on Morbidity and MortalitySemantic proximity Read

Computing the Prevalence and Severity of an Epidemic Using only the Distribution of Simple Tests for Infection ConfirmationSemantic proximity Read

Proactive COVID-19 testing in a partially vaccinated populationSemantic proximity Read

Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is VaccinatedSemantic proximity Read

Asymptomatic SARS-CoV-2 infections tend to occur less frequently in developed nationsSemantic proximity Read

Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocationSemantic proximity Read

Estimation of Annual Exposures and Antibody Kinetics Against Norovirus GII.4 Variants from English Serology Data, 2007-2012Semantic proximity Read

<i>serosim</i>: an R package for simulating serological survey data arising from vaccination, epidemiological and antibody kinetics processesSemantic proximity Read